The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Andrew.Clark.4@glasgow.ac.uk
Floor 1, Zone 3, Admin Block, Queen Elizabeth University Hospital, G51 4TF
Clark, A., Thomas, S., Hamblin, A., Talley, P., Kulasekararaj, A., Grinfeld, J., Speight, B., Snape, K., McVeigh, T. P. and Snowden, J. A. (2023) Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation (BMT): best practice consensus guidelines from the UK Clinical Genetics Group (UK-CGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT). British Journal of Haematology, 201(1), pp. 35-44. (doi: 10.1111/bjh.18682) (PMID:36786081)
Clark, A., Thomas, S., Hamblin, A., Talley, P., Kulasekararaj, A., Grinfeld, J., Speight, B., Snape, K., McVeigh, T. P. and Snowden, J. A. (2023) Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation (BMT): best practice consensus guidelines from the UK Clinical Genetics Group (UK-CGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT). British Journal of Haematology, 201(1), pp. 35-44. (doi: 10.1111/bjh.18682) (PMID:36786081)